Considering its recent success in the market, it’s no wonder Chennai-based Linux Laboratories is one of the emerging global pharmaceutical companies based out of India. If Linux doesn’t ring any bell, its antipsychotic drug brand Penridol might, as it contains Penfluridol molecule & Liposerin brand contains Phopsphotidyl serine) for the first time in India. The drug today is widely accepted by the customers in the country. The company has also launched L Carnosine, which features Dipeptide molecule that’s effective for Autism & Cognition development, under the brand name Ignicar another drug that’s been accepted by its customers PAN India. It’s not surprising that Linux is featured amongst the top-50 Neuro-Psychiatric pharmaceutical companies.

“We have a strong product portfolio of more than 64 brands comprising a total of 180 SKUs (products), including niches like Neuro and Psychiatry. Our high quality products mark a culmination of strict adherence to compliances and world class standards,” asserts Hariharan.P, Co-Founder & Director, Linux Laboratories. The rationale behind Linux earning the trust of millions of patients & healthcare professionals all over India can be attributed to the two pillars of its offerings high quality and affordability.

The quality provided by this ISO certified company can be traced back to not only its strict adherence to the compliances and regulations, but also the way it sources from WHO-GMP certified facilities and outsources 90 percent of the manufacturing process to the country’s top-five manufacturing organizations. “We make the quality foolproof by testing each batch in Govt. of India approved testing labs,” adjoins Ananda Kumar.S, Co-Founder & Director, Linux Laboratories. To top it all off, Linux at periodic intervals performs regular market research on currently available therapy to find out the craters in them thereby providing solutions that fulfill those needs. “To ensure better efficacy, we are using Extended release, Prolonged release, Sustain release, and Tablet in Tablet technologies in our formulations,” divulges Keeerthivasan. K, Co-Founder & Director, Linux Laboratories.

Experience Matters
The co-founder trio, who believed in their capabilities & dreamt of having something that would change the face of Pharmaceuticals for good, had their Eureka moment more than a decade ago and they incepted the company in 2007. With a cumulative experience of more than 60 years, they today envision Linux to be a leading pharmaceutical company in India & to become a significant global player providing high quality, affordable & innovative medicine & treatment solutions.

The rich experience the directors bring across varied skillsets & backgrounds are going to be instrumental towards realizing Linux’s vision. In addition, while offering a multidimensional work environment within the organization that brings about higher growth opportunities through novel drug development strategies and challenging roles with clear responsibilities across a variety of assignments, the company is committed to

hiring exceptional talents who align with the vision. Providing them with enormous opportunities to enhance their technical & soft skills through continuous training & development programs, it’s Linux’s promise to nurture its people to their professional best.

En Route to the Future
After more than a decade Linux today continues to lend its helping hand to the needy in every possible way. The often conducted free medical camps(not less than 300 medical camps are organized across India every year) for inaccessible patients, and taking specialty doctors to the suburbs to conduct the neuropathy screenings which is something unprecedented in the suburbs & remote areas, are mere examples of Linux’s CSR initiatives. It revolves around the vision of medicinal inclusion, affordability, and democratizing the high quality drugs.

Going forward, the company has sketched broad blueprints to realize its vision. The plan to launch its three more unique products for the first time in India by next year is a part of this vision. “According to Awacs, we are ranked 121 with Rs.122 crore of revenue. We currently savor an annual growth rate of 54 percent, and our plans include growing faster,”concludes Hariharan.

Hariharan.P, Co-Founder & Director
Hariharan sets and constantly improves the direction of the company with his extensive experience of 22 years that spans across various designations and categories. For him, entrepreneurship is blood & passion in the veins. He has a strong record of establishing sales and marketing professionals in world class organizations. Hariharan holds a bachelor’s degree in law and science, master’s in business management and is currently pursuing doctorate in marketing.

Keeerthivasan. K, Co-Founder & Director
Keerthivasan has an experience of more than two decades in the Pharmaceutical industry. With an undying passion for business and flair for the industry, he kick started his career with Ranbaxy & handled sales, corporate strategy, human resource & logistics. He is a Science & Computer Applications graduate with Masters in Business Administration.

Ananda Kumar.S, Co-Founder & Director
Anand has completed a professional degree with distinction in Bachelor of Pharmacy and pursued his MBA with specialization in Marketing & Hospital Management from Annamalai University. After his graduation, he pursued a career in ‘Pharmaceutical Marketing’ and headed sales for various companies like Zydus Health Care and Ranbaxy Laboratories in various states.

Quick Facts:
Year of Establishment: 2007
Office: Chennai
Offerings:
Anti-epileptics
•Anti-psychotics
•Anti-depressants
•Nerve pain management
•Nutraceuticals
•Brain Tonics
•Hypnotics

Awards & Recognition:
•Best Emerging Company – 2014
•Outstanding customer Service – 2015
•India's Most Trusted Pharmaceutical Company at the India Healthcare Summit – 2018 held by White Page International
•Pharma Leaders Most Promising & Innovative Company of The Year 2019 - Pharma Leaders Power Brand Awards
•Fastest Growing Indian Company Excellence award by International Achievers Conference -2019